This book just hit the shelves. It's intended for investor institutions in the Pharma industry. You can buy it for the low low price of $2000, but a lot of info can be gleaned just by reading the table of contents.
http://www.researchandmarkets.com/research/rdf6gm/pituitary_acth
It's a 47 page analysis of all the drugs currently in the development pipeline for Cushing's disease.
In particular, it discusses one that I was not aware of called Normocort (COR-003) - it is a modified version of Ketoconazole that is intended to work more effectively against cortisol synthesis and less ef